CDT Equity Inc

CDT Equity Inc. announces a reverse stock split amid extreme volatility—learn how this move could reshape its market cap and investor outlook.

CDT Equity Inc. announces a reverse stock split and a new solid‑form licensing partnership with NJS Foresight to boost share price and unlock drug‑delivery IP.

CDT Equity Inc. is a micro-cap biotech company with a focus on repurposing pharmaceutical assets, but its negative earnings and high volatility pose significant risks, making it a speculative investment opportunity.

CDT Equity Inc. is a small-cap health-care company that has carved a niche for itself by developing clinical assets that larger pharmaceutical entities have deprioritized, offering a compelling investment opportunity for value-oriented investors.